102 related articles for article (PubMed ID: 12058339)
21. Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus).
Van der Geyten S; Byamungu N; Reyns GE; Kühn ER; Darras VM
J Endocrinol; 2005 Mar; 184(3):467-79. PubMed ID: 15749806
[TBL] [Abstract][Full Text] [Related]
22. Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.
Eszlinger M; Jaeschke H; Paschke R
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):393-7. PubMed ID: 17940470
[TBL] [Abstract][Full Text] [Related]
23. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF2.
Diallo EM; Thompson DL; Koenig RJ
Protein Expr Purif; 2005 Apr; 40(2):292-8. PubMed ID: 15766871
[TBL] [Abstract][Full Text] [Related]
24. Thyroid hormone receptor mediates human MDR1 gene expression-Identification of the response region essential for gene expression.
Kurose K; Saeki M; Tohkin M; Hasegawa R
Arch Biochem Biophys; 2008 Jun; 474(1):82-90. PubMed ID: 18395509
[TBL] [Abstract][Full Text] [Related]
25. Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats.
O'Mara BA; Dittrich W; Lauterio TJ; St Germain DL
Endocrinology; 1993 Oct; 133(4):1715-23. PubMed ID: 8404614
[TBL] [Abstract][Full Text] [Related]
26. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
27. Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney.
Schmutzler C; Hamann I; Hofmann PJ; Kovacs G; Stemmler L; Mentrup B; Schomburg L; Ambrugger P; Grüters A; Seidlova-Wuttke D; Jarry H; Wuttke W; Köhrle J
Toxicology; 2004 Dec; 205(1-2):95-102. PubMed ID: 15458794
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations in thyroid nodular disease.
Krohn K; Paschke R
Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
[TBL] [Abstract][Full Text] [Related]
29. Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling.
Huang YH; Liao CH; Chen RN; Liao CJ; Lin KH
J Cell Physiol; 2010 Feb; 222(2):347-56. PubMed ID: 19859911
[TBL] [Abstract][Full Text] [Related]
30. Mammary gland carcinoma-related increase of type I iodothyronine 5'-deiodinase activity in Sprague-Dawley rats.
Macejová D; Líska J; Brtko J
Gen Physiol Biophys; 2001 Sep; 20(3):293-302. PubMed ID: 11765219
[TBL] [Abstract][Full Text] [Related]
31. Type 1 iodothyronine deiodinase activity and mRNA expression in rat thyroid tissue with different iodine intakes.
Wang K; Sun YN; Liu JY; Yan YQ; Chen ZP
Chin Med J (Engl); 2006 Nov; 119(22):1899-903. PubMed ID: 17134589
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant arthritis in the rat is associated with decreased binding of nuclear receptors to thyroid hormone responsive element in spleen extracts.
Brtko J; Jurcovicová J; Schmutzler C; Rokyta R; Svík K; Bobál'ová J
Gen Physiol Biophys; 1998 Dec; 17(4):341-7. PubMed ID: 10191419
[TBL] [Abstract][Full Text] [Related]
33. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
[TBL] [Abstract][Full Text] [Related]
35. The role of thyroid hormone receptor DNA binding in negative thyroid hormone-mediated gene transcription.
Wulf A; Wetzel MG; Kebenko M; Kröger M; Harneit A; Merz J; Weitzel JM
J Mol Endocrinol; 2008 Jul; 41(1):25-34. PubMed ID: 18562675
[TBL] [Abstract][Full Text] [Related]
36. Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.
Berry MJ; Grieco D; Taylor BA; Maia AL; Kieffer JD; Beamer W; Glover E; Poland A; Larsen PR
J Clin Invest; 1993 Sep; 92(3):1517-28. PubMed ID: 8104199
[TBL] [Abstract][Full Text] [Related]
37. Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5'-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers.
Köhrle J
Curr Top Pathol; 1997; 91():83-116. PubMed ID: 9018918
[No Abstract] [Full Text] [Related]
38. Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1.
Gross M; Oertel M; Köhrle J
Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):851-6. PubMed ID: 7702583
[TBL] [Abstract][Full Text] [Related]
39. Graves' disease, thyroid nodules and thyroid cancer.
Belfiore A; Russo D; Vigneri R; Filetti S
Clin Endocrinol (Oxf); 2001 Dec; 55(6):711-8. PubMed ID: 11895209
[No Abstract] [Full Text] [Related]
40. Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels.
Kim BW; Daniels GH; Harrison BJ; Price A; Harney JW; Larsen PR; Weetman AP
J Clin Endocrinol Metab; 2003 Feb; 88(2):594-8. PubMed ID: 12574186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
